What are the treatment options for a patient with stress urinary incontinence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Stress Urinary Incontinence

Begin with supervised pelvic floor muscle training (PFMT) for at least 3 months before considering surgical intervention, as this first-line conservative approach achieves up to 70% symptom improvement and is recommended by all major guidelines. 1, 2, 3

First-Line Conservative Management

Pelvic Floor Muscle Training

  • Supervised PFMT programs are more than 5 times as effective as no treatment and significantly superior to unsupervised or leaflet-based approaches. 2, 4, 5
  • The training must involve repeated voluntary pelvic floor muscle contractions (Kegel exercises) taught by a healthcare professional such as a specialized physiotherapist or continence nurse. 2, 4
  • Continue PFMT for a minimum of 3 months before declaring treatment failure, as benefits accumulate over time. 2, 3
  • Adding dynamic lumbopelvic stabilization (DLS) to standard PFMT improves day and night urine control, reduces leakage severity, and enhances quality of life compared to PFMT alone. 2, 3

Adjunctive Conservative Measures

  • Weight loss programs should be implemented for obese patients (BMI ≥30), as this directly improves stress incontinence symptoms with a number needed to treat of 4. 2, 3, 4
  • Continence pessaries (typically ring pessaries) provide mechanical support to the urethra and bladder neck, restoring the urethrovesical angle and preventing leakage during increased intra-abdominal pressure. 3, 6
  • Pessaries are particularly appropriate for women not bothered enough to pursue surgical therapy or who prefer non-surgical management. 3

Critical Pitfall to Avoid

  • Do not prescribe systemic pharmacologic therapy for pure stress urinary incontinence—no medication has been shown effective for this condition. 4, 6

Surgical Treatment Options

When to Consider Surgery

  • Proceed to surgical evaluation only after an adequate trial (minimum 3 months) of supervised conservative management has failed to adequately control symptoms. 1, 2, 4
  • The degree of bother and impact on quality of life should drive the decision for surgical intervention, not just the presence of leakage. 1, 2

Surgical Procedures (in order of evidence strength)

Midurethral Slings (MUS)

  • Midurethral slings represent the most extensively studied surgical option with the strongest evidence supporting their effectiveness, achieving 51-88% success rates. 1, 2, 3
  • Retropubic midurethral sling (RMUS) has better long-term outcomes for severe stress incontinence cases. 2, 3
  • Transobturator midurethral sling (TMUS) has lower risk of bladder perforation but higher risk of groin pain. 3
  • Single-incision slings (SIS) are emerging as viable options with accumulating long-term data, though their durability requires further confirmation. 2, 3

Autologous Fascia Pubovaginal Sling

  • This is an excellent alternative for patients concerned about mesh complications, with 85-92% success rates at 3-15 years follow-up. 2, 3
  • Consider this option particularly for patients who express anxiety about synthetic mesh after counseling. 2, 3

Colposuspension (Burch Procedure)

  • Remains an effective surgical treatment supported by robust evidence, though less commonly performed than midurethral slings. 2, 6

Urethral Bulking Agents

  • Reduce leakage but effectiveness generally decreases after 1-2 years, making them less durable options. 2, 6
  • Reserve for patients who are poor surgical candidates or desire minimally invasive options. 6

Pre-Operative Counseling Requirements

  • Pre-operative counseling regarding MUS mesh complications results in reduced patient concern, greater willingness to proceed, and higher satisfaction. 2, 3
  • Inform patients that success rates range from 51-88% and symptoms may recur requiring additional treatment. 2
  • Discuss potential complications including direct injury to the lower urinary tract, hemorrhage, infection, bowel injury, wound complications, and mesh-specific complications. 4

Intraoperative Requirements

  • Perform cystoscopy during midurethral sling or fascial pubovaginal sling procedures to confirm lower urinary tract integrity and absence of foreign body within the bladder or urethra. 1

Additional Evaluations for Non-Index Patients

Perform urodynamic testing at your discretion for patients with: 1

  • History of prior anti-incontinence surgery
  • History of prior pelvic organ prolapse surgery
  • Mismatch between subjective and objective measures
  • Significant voiding dysfunction
  • Significant urgency, urgency urinary incontinence, or overactive bladder symptoms
  • Elevated post-void residual per clinical judgment
  • Unconfirmed stress urinary incontinence
  • Neurogenic lower urinary tract dysfunction

Common Pitfalls to Avoid

  • Do not proceed to surgery before an adequate trial (minimum 3 months) of supervised conservative management. 2, 4
  • Do not ignore coexisting conditions such as high-grade prolapse, urgency-predominant mixed incontinence, or incomplete bladder emptying, as these affect treatment selection and outcomes. 1, 2
  • Do not perform cystoscopy for diagnostic evaluation in index patients unless there is concern for urinary tract abnormalities. 1
  • Do not neglect to counsel patients about the potential need for additional treatments if symptoms recur. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Stress Incontinence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Female Stress Urinary Incontinence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Urinary Incontinence in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Stress urinary incontinence.

Obstetrics and gynecology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.